Our Thoughts

BRANDED DRUG NAME APPROVALS – 2018 IN REVIEW

 

 

FDA and EMA 2018 approvals:

Pharmaceutical product naming in the US and Europe is characterized by the broad array of different name types in use, ranging from the more identifiably suggestive to the outright arbitrary.  The following PDF outlines a number of trends in name type approvals by both agencies in 2018.

 

PFB, Branded drug name approvals, 2018

 

To contact Purple Fire Branding, specialists in brand naming, research and design, please telephone +44 (0)20 8166 1853 or email: info@purplefirebranding.com